Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices 106491 

based surveys and assessments 

administered to participants in 

Academies and Workshops. 

There are no significant changes to 

the instruments. The name of the TA 

provider was changed and that has been 

updated. 

Respondents: Child welfare and court 

professionals. 

ANNUAL BURDEN ESTIMATES

Instrument Total number 

of respondents 

Total number 

of responses 

per respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Annual burden 

hours 

Workshop Feedback Survey .................................... 480 1 0.07 46.1 15 

Academy Feedback Survey ..................................... 1,050 1 0.07 73.5 25 

Pre/Post Academy Assessment .............................. 1,050 2 0.22 462 154 

Estimated Total Annual Burden Hours ............. .......................... ............................ .......................... .......................... 194 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 42 U.S.C. 5106(b)(5); 42 

U.S.C. 5113(b)(4); 42 U.S.C. 629h. 

Mary C. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2024–31119 Filed 12–27–24; 8:45 am] 

BILLING CODE 4184–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; National Youth in Transition 

Database (NYTD) and Youth Outcomes 

Survey (Office of Management and 

Budget #0970–0340) 

AGENCY: Children’s Bureau, 

Administration for Children and 

Families, Department of Health and 

Human Services. 

ACTION: Request for public comments. 

SUMMARY: The Administration for 

Children and Families (ACF) is 

requesting a three-year extension of the 

National Youth in Transition Database 

(NYTD) and Youth Outcomes Survey 

(Office of Management and Budget 

(OMB)#: 0970–0340, expiration date 

May 31, 2025). There are no changes 

requested to the form. 

DATES: Comments due February 28, 

2025. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

infocollection@acf.hhs.gov. Identify all 

requests by the title of the information 

collection. 

SUPPLEMENTARY INFORMATION: 

Description: The Foster Care 

Independence Act of 1999 (42 U.S.C. 

1305 et seq.) as amended by Public Law 

106–169 requires state child welfare 

agencies to collect and report to ACF 

data on the characteristics of youth 

receiving independent living services 

and information regarding their 

outcomes. The regulation implementing 

the NYTD, listed in 45 CFR 1356.80, 

contains standard data collection and 

reporting requirements for states to meet 

the law’s requirements. Additionally, 

the Family First Prevention Services Act 

of 2017 (House of Representatives 253) 

further outlines the expectation of the 

collection and reporting of data and 

outcomes regarding youth who are in 

receipt of independent living services. 

ACF will continue to use the 

information collected under the 

regulation to track independent living 

services, assess the collective outcomes 

of youth, and potentially to evaluate 

state performance regarding those 

outcomes consistent with the law’s 

mandate. 

Respondents: State agencies that 

administer the Chafee Foster Care 

Program for Successful Transition to 

Adulthood (Chafee program) report on 

the young people who are served by the 

program and who complete the youth 

outcomes survey. 

Annual Burden Estimates 

The annual burden estimates are 

based on data to inform 2025 estimates. 

Estimates for years further out are likely 

to be similar, but the number of youth 

respondents and time to complete the 

state data file may fluctuate and more 

detail will be provided in the 

submission to OMB and the 

corresponding notice published in the 

Federal Register. 

Instrument Total number 

of respondents 

Number of responses 

per respondent 

Average burden 

hours per 

response 

Annualized 

burden hours 

State Data File ................................................................................. 52 2 (annually) ................. 1,317 136,968 

Youth Outcomes Survey .................................................................. 9,300 1 .................................. 0.5 4,650 

Estimated Total Annual Burden 

Hours: 141,618. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 


ddrumheller on DSK120RN23PROD with NOTICES1
106492 Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: NYTD is authorized by 

Public Law 106–169, enacted December 

14, 1999. This public law establishes the 

John H. Chafee Foster Care 

Independence Program (CFCIP) now 

known as Chafee Foster Care Program 

for Successful Transition to Adulthood 

(Chafee program) at section 477 of the 

Social Security Act. NYTD data are 

collected pursuant to 45 CFR 1356.80. 

Mary C. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2024–31087 Filed 12–27–24; 8:45 am] 

BILLING CODE 4184–73–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–E–0223] 

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; OMISIRGE 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or the Agency) has 

determined the regulatory review period 

for OMISIRGE and is publishing this 

notice of that determination as required 

by law. FDA has made the 

determination because of the 

submission of an application to the 

Director of the U.S. Patent and 

Trademark Office (USPTO), Department 

of Commerce, for the extension of a 

patent which claims that human 

biological product. 

DATES: Anyone with knowledge that any 

of the dates as published (see 

SUPPLEMENTARY INFORMATION) are 

incorrect must submit either electronic 

or written comments and ask for a 

redetermination by February 28, 2025. 

Furthermore, any interested person may 

petition FDA for a determination 

regarding whether the applicant for 

extension acted with due diligence 

during the regulatory review period by 

June 30, 2025. See ‘‘Petitions’’ in the 

SUPPLEMENTARY INFORMATION section for 

more information. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. The https://

www.regulations.gov electronic filing 

system will accept comments until 

11:59 p.m. Eastern Time at the end of 

February 28, 2025. Comments received 

by mail/hand delivery/courier (for 

written/paper submissions) will be 

considered timely if they are received 

on or before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2024–E–0223 for ‘‘Determination of 

Regulatory Review Period for Purposes 

of Patent Extension; OMISIRGE.’’ 

Received comments, those filed in a 

timely manner (see ADDRESSES), will be 

placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with § 10.20 (21 

CFR 10.20) and other applicable 

disclosure law. For more information 

about FDA’s posting of comments to 

public dockets, see 80 FR 56469, 

September 18, 2015, or access the 

information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

FOR FURTHER INFORMATION CONTACT: 

Beverly Friedman, Office of Regulatory 

Policy, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 51, 

Rm. 6200, Silver Spring, MD 20993, 

301–796–3600. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Drug Price Competition and 

Patent Term Restoration Act of 1984 


ddrumheller on DSK120RN23PROD with NOTICES1